Evidence map›Paper›PMID 30014838›Full record

ArticleEmerging infectious diseases2018

Novel Enterobacter Lineage as Leading Cause of Nosocomial Outbreak Involving Carbapenemase-Producing Strains.

Racha Beyrouthy, Marion Barets, Elodie Marion, Cédric Dananché, Olivier Dauwalder, Frédéric Robin, Lauraine Gauthier, Agnès Jousset, Laurent Dortet, François Guérin and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Adaptation and performance evaluation of the French society of microbiology algorithm for detection of carbapenemase-producing enterobacterales using VITEK2 antibiotic susceptibility testing system.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Article
  5. Genomic Study of High-Risk Clones ofAntibiotics (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Emergence of a Novel Lineage and Wide Spread of aAntibiotics (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Occurrence ofAntibiotics (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Changing Face of the FamilyClinical microbiology reviews · 2021
    Review
  18. Dissemination of Extended-Spectrum-β-Lactamase-ProducingAntimicrobial agents and chemotherapy · 2021
    Article
  19. Article
  20. Development of a Molecular Serotyping Scheme forFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Racha Beyrouthy
Marion Barets
Elodie Marion
Cédric Dananché
Olivier Dauwalder
Frédéric Robin
Lauraine Gauthier
Agnès Jousset
Laurent Dortet
François Guérin
Thomas Bénet
Pierre Cassier
Philippe Vanhems
Richard Bonnet
Assistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Besançon · FRHospices Civils de Lyon · FRUniversité Claude Bernard Lyon 1 · FRCentre Hospitalier Universitaire de Caen Normandie · FRCentre Léon Bérard · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated unusual carbapenemase-producing Enterobacter cloacae complex isolates (n = 8) in the novel sequence type (ST) 873, which caused nosocomial infections in 2 hospitals in France. Whole-genome sequence typing showed the 1-year persistence of the epidemic strain, which harbored a bla

Indexed as

Cross InfectionDisease OutbreaksAgedAged, 80 and overAnti-Bacterial Agentsbeta-LactamasesDrug Resistance, Multiple, BacterialEnterobacter cloacaeEnterobacteriaceae InfectionsFemaleGene Expression Regulation, BacterialGene Expression Regulation, EnzymologicHumansMaleMiddle AgedAnti-Bacterial Agentsbeta-Lactamasesmetallo-beta-lactamase VIM-4, Enterobacter cloacaeantimicrobial resistancebacteriabeta-lactamaseCarbapenemasecarbapenemase-producing EnterobacteriaceaeCPEEnterobacter cloacae complexEnterobacteriaceaenext-generation sequencingnosocomial outbreakVIM-4

Identifiers

PMID30014838
PMCPMC6056098
OpenAlexW2873209331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.